ClinicalTrials.Veeva

Menu

Association of Single Nucleotide Polymorphisms (SNPs) in Metalloproteinases (MMPs) Genes With the Risk of Primary Knee Osteoarthritis in Greek Population.

A

Aristotle University Of Thessaloniki

Status

Enrolling

Conditions

Metalloproteinase SNPs -1575 G/A MMP-2, 836 A/G MMP-9 and -77 A/G MMP-13 and Risk for Developing Knee Osteoarthritis in Greek Population

Treatments

Other: No intervention, Patients selection based on clinical symptoms and radiological imaging

Study type

Observational

Funder types

Other

Identifiers

NCT04463290
197/17.6.2020

Details and patient eligibility

About

Does the presence of gene polymorphisms -1575G / A in the MMP-2 gene, 836A / G in the MMP-9 gene and -77A / G in the MMP-13 gene, affect the risk of developing idiopathic knee osteoarthritis in the Greek population?

Full description

This is a prospective case-control study in which the patients' genotype will be studied against the genotype of the controls. The study is prospective and not retrospective, as data will be collected from patients with primary knee osteoarthritis as well as the control group from the outset. The study intends to include 200 people. The first group consists of 100 individuals suffering from knee osteoarthritis, while the second group will include 100 healthy controls without osteoarthritis. From each one DNA will be isolated and analyzed from collected blood. The prospective study allows valid data to be collected on patient demographics and disease severity. Due to the large number of cases of the disease, it is estimated that the necessary specimens will be collected within a reasonable time from the beginning of this thesis. The choice of the patient-control study is necessary to limit the influence of confounding factors (age, gender, obesity, etc.). This type of study includes rigorous selection of patients and controls with specific entry and exclusion criteria, selection of controls based on matching patient characteristics, stratification, and subgroup analyzes. The final result will be a comparison of the incidence of specific gene polymorphisms between patients with knee osteoarthritis and the normal population.

Enrollment

200 estimated patients

Sex

All

Ages

55 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with primary knee osteoarthritis are selected based on clinical symptoms and radiological imaging with a score at least 2 on the Kellgren & Lawrence scale.
  • Patients without symptomatology or radiographic image of knee osteoarthritis (score <2 on Kellgren & Lawrence scale) will be selected as controls.

Exclusion criteria

  • systemic inflammatory disease
  • rheumatic disease
  • liver disease
  • renal failure
  • neoplasm or other chronic disease

Trial design

200 participants in 2 patient groups

Knee Osteoarthritis Patients Group
Description:
Patients suffering from primary knee osteoarthritis
Treatment:
Other: No intervention, Patients selection based on clinical symptoms and radiological imaging
Control Group
Description:
Healthy people without suffering from primary knee osteoarthritis
Treatment:
Other: No intervention, Patients selection based on clinical symptoms and radiological imaging

Trial contacts and locations

1

Loading...

Central trial contact

Eleftherios Tsiridis, Professor; Christos Milaras, Phd Cand.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems